#United States #Nashville #Tennessee Oncology #FACT #Cellular Therapy

Tennessee Oncology Achieves Pioneering Accreditation

In a groundbreaking development for community healthcare, Tennessee Oncology has achieved the prestigious FACT Community IEC Accreditation. This recognition positions them as the first community-based oncology program to be accredited under the standards set forth by the Foundation for the Accreditation of Cellular Therapy (FACT). This milestone is pivotal as it symbolizes a significant shift in making cellular therapies, like CAR T-cell therapy, more accessible to patients who need them.

FACT is an influential organization dedicated to improving the quality and safety of cellular therapy worldwide. Their accreditation process is rigorous, ensuring that accredited programs maintain high standards of care. The organization's commitment to expanding access to life-saving therapies aligns with its goal to foster quality and safety in emerging treatments.

The recent accreditation of Tennessee Oncology highlights a new pathway for delivering high-quality immune effector cell therapies effectively within the community setting. Traditionally, advanced therapies have been primarily offered in academic medical centers, creating barriers for patients who might struggle with travel and access to specialty care. Dr. Navneet Majhail, FACT President, emphasized the significance of this step, indicating that it reflects both the quality of care at Tennessee Oncology and the potential for replication in other community settings.

In 2025, FACT published the Community IEC Standards, designed specifically to suit the needs of community oncology programs while preserving a strong focus on quality and patient safety. The development of these standards involved a collaborative effort from multiple stakeholders in the healthcare arena, ensuring that they are robust yet practical for community settings.

Dr. Michael Byrne, the Cellular Therapy Program Director at Tennessee Oncology, expressed his pride in the accreditation. He highlighted the dedication of their entire team towards advancing clinical research and delivering the highest standard of care to patients. The achievement not only marks a momentous occasion for the organization but also sets a precedent for future initiatives aimed at improving the delivery of care to patients receiving cellular therapies.

In addition to the benefits for patients, this shift signifies a major step towards democratizing access to advanced therapies, reducing travel-related burdens, improving adherence to treatment, and addressing the disparities that often stem from geographical location and socioeconomic status. Studies have shown that decreasing the distance patients need to travel for treatment dramatically increases the likelihood that they will receive essential therapies like CAR T-cell treatment, underscoring the importance of localized care.

Dr. Davey Daniel, Chief Medical Officer at OneOncology, stated that the accreditation achieved by Tennessee Oncology illustrates that high-quality CAR T delivery can occur outside of traditional academic settings. This milestone is vital for patients in rural and underserved areas who depend on seamless access to advanced therapies within their own communities.

As FACT commends Tennessee Oncology for their accomplishment, they encourage other community oncology programs to consider pursuing accreditation as part of a deeper commitment to improving patient outcomes through expanded access to cellular therapies. By highlighting this vital accreditation, FACT hopes to inspire a wave of similar initiatives across the country, ensuring that every patient has the opportunity to receive potentially life-saving treatment, regardless of their location.

Conclusion

In conclusion, Tennessee Oncology's achievement of the FACT Community IEC Accreditation not only paves the way for better access to cellular therapies but also represents a significant change in how advanced cancer treatments can be delivered in community settings. The continuous evolution of healthcare standards is crucial in the fight against cancer, and steps like these make it apparent that quality care can indeed exist outside of major metropolitan hospitals. As more programs adapt and strive for excellence, the hope is that all patients will benefit from high-quality, accessible care close to home.